Dasatinib | High-Quality Pharmaceutical Reference Standard
Dasatinib is a tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It works by inhibiting BCR-ABL and Src family kinases, thereby suppressing malignant cell proliferation. Dasatinib API is manufactured under GMP-compliant conditions and is suitable for oral solid dosage formulations, including tablets.
Dasatinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 10
